00000cam 2200000zi 4500 9.949859 CaOODSP 20251229124630 m o d f cr mn||||||||| 250407e202508##onc o f000 0 eng d 9780660768533 CaOODSP eng rda CaOODSP n-cn--- H164-391/2025E-PDF Guidance on biocide : annual confirmation and fees for the right to sell biocides. [August 2025 edition]. Ottawa, Ontario : Health Canada = Santé Canada, August 2025. ©2025 1 online resource (13 pages) text txt rdacontent computer c rdamedia online resource cr rdacarrier Cover title. Issued also in French under title: Lignes directrices sur la confirmation annuelle des biocides et sur les frais pour le droit de vendre des biocides. "Date adopted: 2025/05/31; Date posted: 2025/08/15; Effective date: 2025/05/31"--Page 2. "Once a biocide is authorized for sale in Canada, industry must pay an annual fee to retain the right to sell the biocide in Canada. Health Canada has charged fees since 1995 to recover some of the associated costs with post-market regulatory activities such as assessing safety signals and trends and communicating about risks. This document provides guidance on how fees for the right to sell biocides will be administered in accordance with the Food and Drugs Act and as stipulated in the Fees in Respect of Drugs and Medical Devices Order"--Page 5. Disinfectants industry Government policy Canada. Fees, Administrative Canada. Canada. Health Canada, issuing body. Lignes directrices sur la confirmation annuelle des biocides et sur les frais pour le droit de vendre des biocides. (CaOODSP)9.949860 Guidance on biocide : [November 2025 edition] (CaOODSP)9.957053 PDF 415 KB https://publications.gc.ca/collections/collection_2025/sc-hc/H164-391-2025-eng.pdf 250008